Jørn Carlsen

Medicine & Life Sciences

1. Alemtuzumab 17%
2. Aspergillosis 15%
3. Bronchiolitis 15%
4. Central Serous Chorioretinopathy 18%
5. Chronic Obstructive Pulmonary Disease 45%
6. dofetilide 39%
7. Elasticity Imaging Techniques 30%
8. Embolectomy 30%
9. Evaluation Studies 34%
10. Exome 15%
11. Familial Primary Pulmonary Hypertension 33%
12. Hyperprolactinemia 15%
13. Left Ventricular Dysfunction 29%
14. Left Ventricular Function 16%
15. Lung 46%
16. Lung Transplantation 100%
17. Magnetic Resonance Imaging 16%
18. Mediastinal Fibrosis 20%
19. microfibrillar protein 22%
20. Morbidity 18%
21. Mortality 46%
22. Myocardial Infarction 36%
23. Placebos 16%
24. Pulmonary Arterial Hypertension 52%
25. Pulmonary Artery 15%
26. Pulmonary Embolism 50%
27. Pulmonary Hypertension 78%
28. Sample Size 15%
29. Sarcoidosis 19%
30. Sildenafil Citrate 15%
31. Stroke Volume 17%
32. Survival 23%
33. trandolapril 61%
34. Transplant Recipients 16%
35. Voriconazole 16%